CLOSE

Benchmark Investments

ITI Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
17.13 -0.01(-0.07%) NAV as on 25 Jun 2026
2.18 % 1 M
6.22 % 1 Y
19.74 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.38

As on 31 May, 2026
Age :

4 yrs 7 m

Since 08 11 ,2021
Exit Load :

0.5%

AUM :

237.99 Crs

Portfolio Price To Book Value :

7.97

Investing Style :

Large Growth

Min. Investment :

SIP 500 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Animesh Singh,Nilay Dalal

Launch Date :

08-Nov-21

Scheme Benchmark :

NA

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies engaged in Pharma and Healthcare.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2026
Others 1.99 %
Equity 98.01 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.25 %
Divi's Laboratories Ltd.8.43 %
Apollo Hospitals Enterprise Ltd.6.20 %
Laurus Labs Ltd.5.06 %
Torrent Pharmaceuticals Ltd.4.90 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs71.33
Hospital & Healthcare Services19.14
Plastic Products1.47
Industrial Gases & Fuels1.30
Insurance1.22
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)9.528.9413.5315.6414.73
Net Assets(Rs Crores) (as on 31-Mar-2026) 175.15 135.04 160.39 213.78 211.30
Scheme Returns(%)(Absolute)-4.83-6.0951.0514.23-4.13
B'mark Returns(%)(Absolute)NANANANANA
Category Rank74/7564/7629/9013/10271/120

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2025-20264.99-3.86-0.62-6.15
2024-20254.5219.842.86-10.24
2023-202414.798.1111.209.63
2022-2023-9.488.780.04-4.62
2021-2022NANANA-7.30

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ITI Pharma & Healthcare Fund-Reg(G)Very HighEquity17.13-0.01(-0.07%)NAV As on 25 Jun, 202608-Nov-2021Inception Date237.99AUM In Cr.6.22%1Y19.74%3YNA%5Y12.32%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity42.63-0.14(-0.33%)NAV As on 25 Jun, 202613-Jul-2018Inception Date6,453.52AUM In Cr.9.08%1Y26.36%3Y16.16%5Y19.99%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity484.07-0.82(-0.17%)NAV As on 25 Jun, 202614-Jul-1999Inception Date4,565.95AUM In Cr.14.64%1Y24.36%3Y16.52%5Y16.18%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity42.95-0.02(-0.06%)NAV As on 25 Jun, 202602-Jul-2018Inception Date3,090.51AUM In Cr.14.06%1Y23.97%3Y14.43%5Y20.02%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity34.30-0.13(-0.38%)NAV As on 25 Jun, 202610-Jul-2019Inception Date950.31AUM In Cr.13.73%1Y23.02%3Y13.22%5Y19.36%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd